Abstract
In a previous study we observed that mast cell degranulation might be associated to bone resorption. To verify this assumption, the efficiency of cromoglycate was assessed on a synchronized sequence of bone remodeling induced in male Wistar rats along the mandibular cortex. After 4 days (time of osteoclastic peak in this model), cromoglycate (15/mg/kg and 30 mg/kg/d per os) decreased the number of degranulating mast cells, especially in the population adjacent to the bone surface. Concomitantly the extent of resorption surface was decreased vs untreated animals. Active osteoclasts were lower whereas the total number of osteoclasts (both active and inactive) was not statistically modified. The mean osteoclast-bone interface was not modified. No dose effect was found. These data indicate that mast cell degranulation is involved in the events leading to osteoclast resorption, presumably in the mechanisms providing osteoclast access to bone surface.
Similar content being viewed by others
References
E. Hills, C. R. Dunstan and R. A. Evans,Bone metabolism in systemic mastocytosis. J. Bone Joint. Surg.63A, 665–669 (1981).
M. D. Fallon, R. B. Whyte, R. B. Craig and S. L. Teitelbaum,Mast cell proliferation in postmenopausal osteoporosis, Calcif. Tissue Int.35, 29–31 (1983).
M. J. McKenna and B. Frame,The mast cell and bone. Clin. Orthop.200, 226–233 (1985).
J. L. Saffar and M. Klapisz-Wolikow,Changes in mast cell number during the activation phase of an induced synchronized remodeling sequence in the rat. Bone11, 369–372 (1990).
R. E. C. Altounyan,Review of clinical activity and mode of action of sodium cromoglycate, Clin. Allergy.10, 481–489 (1980).
P. Tran Van, A. Vignery and R. Baron,Cellular kinetics of the bone remodeling sequence in the rat. Anat. Rec.202, 445–451 (1982).
N. A. Soter, K. F. Austen and S. I. Wasserman,Oral disodium cromoglycate in the treatment of systemic mastocytosis. N. Engl. J. Med.301, 465–469 (1979).
R. R. Alexander,Disodium cromoglycae in the treatment of systemic mastocytosis involving only bone. Acta Haemat.74, 108–110 (1985).
J. L. Saffar and P. Leroux,Role of prostaglandins in bone resorption in a synchronized remodeling sequence in the rat. Bone9, 141–145 (1988).
P. J. McMillan, R. A. Dewri, E. E. Joseph, R. L. Schultz and L. J. Deftos,Rapid changes of light microscopic indices of osteoclast-bone relationships correlated with electron microscopy. Calcif. Tissue Res.44, 399–405 (1989).
J. A. Kiernan,The involvement of mast cells in vasodilatation due to axon reflexes in injured skin. Quart. J. Exp. Physiol.57, 311–317 (1972).
S. R. Walker, M. E. Evans and A. J. Richards,The fate of [14 C] disodium cromoglycate in man. J. Pharm. Pharmacol.24, 525–531 (1972).
J. A. Hamilton, S. R. Lingelbach, N. C. Partridge and T. J. Martin,Stimulation of plasminogen activator in osteoblast-like cells by bone resorbing hormones. Biochem. Biophys. Res. Commun.122, 230–236 (1984).
J. K. Heath, S. J. Atkinson, M. C. Meikle and J. J. Reynolds,Mouse osteoblasts synthesize collagenase in response to bone resorbing agents. Biochim. Biophys. Acta802, 151–154 (1984).
S. Sakamoto and M. Sakamoto,Bone collagenase, osteoblasts and cell-mediated bone resorption. InBone and mineral research/4. (Ed. W. A. Peck) pp. 49–102, Elsevier, Amsterdam 1986.
J. S. Bartholomew and D. E. Woolley,Plasminogen activator release from cultured murine mast cells. Biochem. Biophys. Res. Commun.153, 540–544 (1988).
D. E. Woolley, J. S. Batholemew, D. J. Taylor and J. M. Evanson,Mast cells and rheumatoid arthritis, In:Mast cell and basophil differentiation and function in health and disease. (Eds. S. J. Galli and K. F. Austen) pp. 183–193, Raven Press, New York 1989.
S. Chock and E. A. Schmauder-Cock,Synthesis of prostaglandins and eicosanoids by the mast cell secretory granule. Biochem. Biophys. Res. Commun.156, 1308–1315 (1988).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dobigny, C., Saffar, J.L. Partial inhibition of bone resorption by disodium cromoglycata in a synchronized model of bone remodeling. Agents and Actions 33, 326–329 (1991). https://doi.org/10.1007/BF01986581
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01986581